The report contains ten-year analysis with the following sections
contact us for pricing
Check out our sample pages |
Many companies now available
Search to find companies of interest
read summary of their published patent
the company report contains more information
cytomx therapeutics | 251 |
cytomx | 5 |
bristol-myers squibb company | 3 |
cytomx therapetuics | 3 |
cytomx | 4 |
cytomx therapeutics | 2 |
Title of patent family (most common patent title) |
Family members |
Filing year |
---|---|---|
modified antibody compositions, methods of making and using thereof | 34 | 2009 |
activatable antibodies that bind epidermal growth factor receptor and methods of use the… 🛈 | 30 | 2012 |
anti-jagged 1/jagged 2 cross-reactive antibodies, activatable anti-jagged antibodies and… 🛈 | 26 | 2012 |
activatable binding polypeptides and methods of identification and use thereof | 22 | 2007 |
proproteins and methods of use thereof | 22 | 2009 |
anti-pdl1 antibodies, activatable anti-pdl1 antibodies, and methods of use thereof | 15 | 2015 |
anti-cd71 antibodies, activatable anti-cd71 antibodies, and methods of use thereof | 15 | 2015 |
matriptase and u-plasminogen activator substrates and other cleavable moieties and metho… 🛈 | 14 | 2014 |
matrix metalloproteinase substrates and other cleavable moieties and methods of use ther… 🛈 | 14 | 2013 |
multispecific antibodies, multispecific activatable antibodies and methods of using the … 🛈 | 14 | 2013 |